The high-B7H6 group survived for a significantly shorter time than the low-B7H6 group (P<0.0001, Figure 1D), suggesting that B7H6 expression in tumors correlates strongly with poor prognosis in PC patients. This evidence concerns the gene NCR3LG1 and pachyonychia congenita.